A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Idiopathic Hypersomnia · Narcolepsy Type 1 · Narcolepsy Type 2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Takeda Site 1, Shinjuku-ku, Tokyo, Japan

Study leads

Takeda Contact
Study Director
Takeda

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1 · Narcolepsy Type 2 · Idiopathic Hypersomnia

Abroad (travel likely)RecruitingPHASE2

Auburn, United States · Chandler, United States

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1 · Narcolepsy Type 2 · Idiopathic Hypersomnia

Abroad (travel likely)RecruitingPHASE2, PHASE3

Phoenix, United States · Little Rock, United States

A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

Narcolepsy Type 1 · Narcolepsy Type 2 · Idiopathic Hypersomnia

Abroad (travel likely)RecruitingPHASE2

Auburn, United States · Santa Ana, United States

A Novel Approach to Manage Symptoms of Narcolepsy and Idiopathic Hypersomnia

Idiopathic Hypersomnia · Narcolepsy Type 1 (NT 1) · Narcolepsy Type 2 (NT2)

Abroad (travel likely)Recruiting

Macquarie Park, Australia